Kasuwar Maganin Cutar Huntington an kimanta girman a $325 miliyan a 2021, to Dalar Amurka miliyan 1813.18 nan da 2030, nuna a CAGR na 19.5% tsakanin 2022-2030.
A cikin lokacin annabta, ɓangaren haɓaka mafi sauri a cikin kasuwar maganin cututtukan cututtukan ana tsammanin shine wanda ke da mafi girman girma. Wannan ya faru ne saboda haɓakar R&D a cikin hanyoyin magance cututtuka da haɓaka buƙatun samfuran ci-gaba kamar maganin ƙwayoyin cuta ko jiyya na ƙwayoyin cuta. A nan gaba, ana iya haɓaka kasuwa ta hanyar ingantattun shirye-shiryen gwamnati kamar Fast Track Designation (US FDA), wanda ke hanzarta aiwatar da rajista. Sage Therapeutics's miyagun ƙwayoyi SAGE-718 an ba da izini cikin sauri ta hanyar FDA ta Amurka a cikin Satumba 2021 azaman yuwuwar magani ga Cutar Huntington.
Kuna iya Neman sigar Demo na Rahoton Kafin siyan anan: https://market.us/report/huntington-s-disease-treatment-market/request-sample/
Kasuwar Maganin Cutar Huntington: Direbobi
Ƙarfafa ɗaukar Ingantattun Magunguna da Magunguna don Korar Buƙatun Zaɓuɓɓukan Jiyya.
Fadada kasuwa za ta kasance ta hanyar shigar manyan ƴan masana'antu a cikin neman maganin cutar Huntington (HD). Wannan na iya kasancewa saboda karuwar lambobi masu haƙuri da yaduwar cututtuka a Turai da Arewacin Amurka. Ci gaban kasuwa za a taimaka ta rashin biyan buƙatun na HD-gyaran magunguna da hanyoyin kwantar da hankali.
Haɓaka Bincike da Ci gaba don Haɓaka Ci gaban Kasuwa.
Cutar Huntington ba ta da magani. Babu magani ko magani. Wannan yana nufin akwai dama da yawa don bincike da haɓaka sabbin zaɓuɓɓukan warkewa. Wannan zai iya haɓaka haɓakar kasuwa sosai a cikin lokacin hasashen. Shirye-shiryen gwamnati masu yuwuwa waɗanda ke haɓaka haɓaka sabbin magunguna zai zama wani abin da zai haifar da faɗaɗa kasuwa.
Kasuwar Maganin Cutar Huntington: Taƙaitawa
Karancin magunguna yana hana ci gaban kasuwa.
Cutar Huntington tana da ƙayyadaddun adadin magunguna masu lasisi saboda tsauraran ƙa'idodi da ƙuntatawa. Wataƙila wannan zai iya iyakance haɓakar kasuwa a duk tsawon lokacin hasashen. Saboda rashin jin daɗi da ke da alaƙa da cutar Huntington, ƙarancin wayar da kan jama'a a sassa da yawa na duniya, tsauraran ƙayyadaddun izinin magunguna, wasu tsare-tsaren hanyoyin warkewa, da ƙaramin adadin da aka yarda da su zai iya iyakance haɓakar kasuwa.
Mabuɗin Kasuwanci:
Kasuwar Maganin Cutar Huntington ana hasashen samun babban kaso na kasuwa don Sashin Jiyya na Alamun.
Mafi girman kaso ana sa ran za a riƙe ta ɓangaren jiyya na alamun a lokacin hasashen Shekarar. An haɓaka kudaden shiga kashi ta hanyar samun ɗanɗano mai girma da ƙimar amfani don maganin kula da alamun. Wannan bangare yana haifar da babban kudaden shiga saboda buƙatar jiyya da yawa da kuma sa baki ta ƙungiyar musamman.
Lalacewar Motoci da chorea sune babban abin da ake mayar da hankali ga ci gaban warkewa. Chorea har yanzu shine mafi yawan sifofin asibiti na cutar Huntington. Yawancin nazarin warkewa an gudanar da shi a kai. Neurocrine Biosciences, alal misali, ta sanar da cewa valentine ya rage yawan chorea a cikin majinyatan Huntington a cikin gwajin asibiti na Phase 3 da ake kira-KINECT HD a watan Disamba 2021. Wata takarda bincike na Mayu 2021 da aka buga a cikin Brain ya nuna cewa maganin gyaran kwayoyin halitta na iya rage ci gaban bayyanar cututtuka. Wadannan karatun da ke gudana za su taka muhimmiyar rawa wajen tantance rabon kasuwa na wannan bangare a cikin shekaru masu zuwa.
Ci gaban kwanan nan:
Ionis Pharmaceuticals, Inc. ya sanar a cikin Janairu 2022 haɗin gwiwa tare da Roche don kimanta tominersen a cikin gwaji na Phase 2 don maganin cutar Huntington.
Novartis, babban mai kera hanyoyin magance cututtuka don cutar Huntington, ya sanar da cewa an ba Novartis matsayin FDA Fast Track a watan Disamba 2021.
Fasahar Gama gari:
- Valeant Pharmaceuticals
- Teva Pharmaceuticals
- Wave Life Sciences
- Ionis Pharmaceuticals/Roche
- Raptor Pharmaceuticals
- Prana Biotechnology
type
- Symptomatic Therapy
- Maganin Gyara Cuta
Aikace-aikace
- asibitoci
- Cibiyar Nazarin Ruwa ta Ambulatory
Masana'antu, Ta Yanki
- Asiya-Pacific [China, Kudu maso Gabashin Asiya, Indiya, Japan, Koriya, Yammacin Asiya]
- Turai [Jamus, UK, Faransa, Italiya, Rasha, Spain, Netherlands, Turkey, Switzerland]
- Arewacin Amurka [Amurka, Kanada, Mexico]
- Gabas ta Tsakiya & Afirka [GCC, Arewacin Afirka, Afirka ta Kudu]
- Kudancin Amirka [Brazil, Argentina, Columbia, Chile, Peru]
Tambayoyi masu mahimmanci:
- Menene girman kasuwa don maganin cutar Huntington da ke girma a?
- Wanene manyan mahalarta kasuwa don magance cutar Huntington?
- Menene farashin kasuwa da ake tsammani don maganin cutar Huntington a cikin 2031?
- Wane yanki ne ya fi saka jari a kasuwa don magance cutar Huntington?
- Wanene manyan mahalarta kasuwa don magance cutar Huntington?
- Menene sauye-sauyen da ke tasiri kasuwa don maganin cutar Huntington?
- Menene CAGR kasuwar jiyya don cutar Huntington ta girma a tsakanin 2015 da 2021?
- Menene manyan canje-canje a cikin buƙatun masu amfani yayin da tattalin arzikin ke canzawa?
- Wadanne matsaloli SMEs da sanannun masu siyarwa suke fuskanta a kasuwa don magance cutar Huntington?
Ƙarin Rahotanni masu dangantaka daga Shafin Market.us:
Girman Kasuwar Maganin Sikila-Cell na Duniya ya cancanci USD Biliyan 1.9 a cikin 2021 kuma ana hasashen zai fuskanci a 17.9% CAGR lokacin 2023-2032.
Kasuwar Maganin Ciwo Na Zamani Na Duniya ana hasashen don cimma kimar darajar Dalar Amurka 173.53 ta 2031 a CAGR na 7.2%, daga Dalar Amurka 86.58 a shekarar 2021.'
Kasuwar Maganin Warts ana hasashen zai kai ga kimantawa $2.16 Biliyan ta 2032 a CAGR na 4.8%, daga USD 1.63 biliyan a 2021.
Kasuwar Maganin Tabon Kurajen Duniya ana hasashen zai kai ga kimantawa Dalar Amurka 82.59 da 2032 a CAGR of 13.85%, daga Dalar Amurka 27.32 a 2022.
Kasuwancin acromegaly na duniya An mai daraja a Dala miliyan 1,497 a 2021. Ana hasashen girma 7.55% sama da lokacin hasashen.
Game da Kasuwa.us
Market.US (Powered by Prudour Private Limited) ƙwararre ne a cikin zurfin bincike da bincike na kasuwa kuma yana tabbatar da ƙarfinsa a matsayin mai ba da shawara da kamfanin bincike na kasuwa na musamman, baya ga kasancewar rahoton bincike na kasuwa da ake nema da yawa wanda ke samar da kamfani.
Bayanan hulda:
Ƙungiyar Ci gaban Kasuwancin Duniya - Market.us
Adireshin: 420 Lexington Avenue, Suite 300 New York City, NY 10170, Amurka
Waya: +1 718 618 4351 (International), Waya: +91 78878 22626 (Asiya)
email: [email kariya]
ABUBUWAN DA ZA KU GUDU DAGA WANNAN LABARI:
- A cikin lokacin annabta, ɓangaren haɓaka mafi sauri a cikin kasuwar maganin cututtukan cututtukan ana tsammanin shine wanda ke da mafi girman girma.
- an sanar a cikin Janairu 2022 haɗin gwiwa tare da Roche don kimanta tominersen a cikin gwaji na Phase 2 don maganin cutar Huntington.
- Saboda rashin jin daɗi da ke da alaƙa da cutar Huntington, ƙarancin wayar da kan jama'a a sassa da yawa na duniya, tsauraran ƙayyadaddun izinin magunguna, wasu tsare-tsaren hanyoyin warkewa, da ƙaramin adadin da aka yarda da su zai iya iyakance haɓakar kasuwa.
